Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Ankylosing Spondylitis Drugs News Monitoring

Get by Email • RSS

Published on 12:34 GMT

Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active ...

Alfasigma S.p.A announced positive topline results from the OLINGUITO phase 3 clinical trial (NCT05785611; Eudra CT 2022-501354-10-01), evaluating filgotinib (marketed as Jyseleca in approved indications) to treat adult patients with active axial …

Source: Pharmabiz.com - Neutral
Published on 10:15 GMT

Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial

Alfasigma to seek regulatory approval following OLINGUITO study success Alfasigma has announced positive topline results from its OLINGUITO phase 3 trial evaluating filgotinib in adults with active axial spondyloarthritis (axSpA), including both …

Source: PharmaTimes - Neutral
Published on Jul 29, 2025

Alfasigma touts results from phase 3 trial of former Galapagos JAK inhibitor Jyseleca

Once touted as a potential powerhouse treatment for a variety of inflammatory conditions, Galapagos’ JAK inhibitor Jyseleca (filgotinib) saw its expectations tumble with a 2020 FDA rejection to treat rheumatoid arthritis followed by a 2023 failure in a …

Source: Fierce Pharma - Neutral
Published on Jul 28, 2025

4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential

Investing UrosPoteko / iStock After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to outperform as the impact of tariffs on foreign products and services begins to take hold. Many …

Source: 24/7 Wall St. - Pending
Published on Jul 26, 2025

Navigating Pediatric Hidradenitis Suppurativa: A Q&A on Early Diagnosis and Effective Treatment

Hidradenitis suppurativa in pediatric patients can present challenges from delayed diagnosis and resulting anxiety because of the symptoms of the disease. At the Society for Pediatric Dermatology Annual Meeting, Robyn Guo Ku, BS, a medical student at the …

Source: The American Journal of Managed Care - Neutral
Published on Jul 28, 2025

New Approvals Expand Access to Biosimilars for Ophthalmology, Bone, and Joint Conditions

Recent weeks have demonstrated global momentum in the regulatory advancement of biosimilars, with key approvals and positive opinions emerging from the US, Europe, and Canada. These developments are poised to enhance access to affordable, high-quality …

Source: The Center for Biosimilars - Pending
Published on Jul 29, 2025

When a Pair of Hands Restores Hope

When Osbeli walked through the doors of the Doctor Ernesto Guevara de la Serna General Teaching Hospital, she couldn't do it on her own; she was confined to a wheelchair. She had previously been diagnosed with ankylosing spondylitis. In its acute phase …

Source: Periódico 26 - Gov't Propaganda
Published on Jul 25, 2025

Summary of opinion: Taltz, 24/07/2025 Positive

On 24 July 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Taltz. The marketing authorisation holder for this medicinal …

Source: European Medicines Agency - Pending
Published on Jul 25, 2025

Real-World Benefits of Bimekizumab for Psoriatic Arthritis, AxSpA, with Philip Mease, MD

Bimekizumab has continued to demonstrate sustained improvements in disease control and symptoms in people with psoriatic arthritis (PsA) and active axial spondyloarthritis (AxSpA) in long term follow-up data.1,2,3,4 These findings were presented in a …

Source: HCPLive - Pending
Published on Jul 25, 2025

The Top 5 Biosimilar Articles for the Week of July 21

Number 5: Sarfaraz K. Niazi, PhD, argues that the FDA can accelerate biosimilar entry by changing guidance under the Biologics Price Competition and Innovation Act (BPCIA) without needing Congressional approval. Number 4: Tyler Sandahl, PharmD, a clinical …

Source: The Center for Biosimilars - Pending
Published on Jul 29, 2025

Alfasigma sets stage for Jyseleca in axSpA after Phase III win

Alfasigma plans to engage with regulators to seek approval for Jyseleca (filgotinib) in active axial spondyloarthritis (axSpA) following a successful Phase III trial. In the OLIGUITO study (NCT05785611), Jyseleca met the primary endpoint of achieving …

Source: Pharmaceutical Technology - Neutral
Published on Jul 27, 2025

Hope as scientists discover cause of debilitating back pain affecting thousands

By LUKE CHAFER Published: 20:48 EDT, 26 July 2025 | Updated: 20:48 EDT, 26 July 2025 Scientists have pinpointed the cause of a debilitating back problem that affects thousands, leading to hope that it could pave the way for new treatments. Until now the …

Source: Daily Mail - Right-wing

05 days 14:34:34

Featured Releases

Got News to Share? · Submit · See All

Published on July 30, 2025 - 12:25 GMT

NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key ...

-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217, a key biomarker of Alzheimer’s disease pathology, in both the full analysis set (p=0.0019) and in ApoE4 carriers (p=0.0215), supporting CETP inhibition as …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:00 GMT

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 ...

NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical study …

Distribution channels: Technology ...

Published on July 30, 2025 - 09:00 GMT

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC ...

License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom) Combining Rezdiffra with the oral GLP-1, SYH2086, offers potential for a best-in- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 08:10 GMT

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist ...

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on July 30, 2025 - 08:10 GMT

Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines ...

Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025: Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten zur Behandlung …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 05:00 GMT

Communiqué de presse: Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation mé...

Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC5D, se voit accorder la désignation médicament orphelin pour le myélome multiple aux États-Unis Désignation accordée pour l’anticorps monoclonal GPRC5D à base d’immunoglobulines G pour le traitement …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on July 30, 2025 - 05:00 GMT

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma Designation granted for IgG1-based GPRC5D monoclonal antibody for the potential treatment of patients with relapsed or refractory multiple …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on July 30, 2025 - 10:55 GMT

GLP-1 Analogues Market Growth Driven by Diabetes and Obesity Trends | DataM Intelligence

GLP-1 analogues market grows fast with rising diabetes & obesity, driven by innovation, weight loss benefits, and strategic pharma investments. NEW YORK, NY, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Glucagon-like peptide 1 (GLP 1) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 835,429,398 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 07/17/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on July 30, 2025 - 13:24 GMT

ProMeals Shares Proven Health Benefits of Home-Prepared Meals to Reduce Risk of Type 2 Diabetes

HOUSTON, TX, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- ProMeals has continued to support individuals seeking better control over their nutrition by offering meals designed to align with specific health goals. As concerns around rising …

Distribution channels: Business & Economy, Companies ...
Published on July 30, 2025 - 13:17 GMT

InjectCo opens newest location in Austin

Personalized, nonsurgical aesthetic services are now available on Burnet Road. AUSTIN, TX, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- InjectCo, a fast-growing Texas-based medical aesthetics brand, officially opened its newest clinic in …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on July 30, 2025 - 13:12 GMT

Skin Grafting Market projected to reach US$2.014 billion by 2030 at a significant CAGR of 6.15%

The skin grafting market is anticipated to grow at a CAGR of 6.15% from US$1.495 billion in 2025 to US$2.014 billion by 2030. NEW YORK, NY, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- According to a new study published by Knowledge …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:12 GMT

Enteral Feeding Devices Market to Reach $$9.8 Billion Globally by 2035, Growing At a CAGR of 6.7%

The market is driven by rise in geriatric population, surge in preterm birth, and rise in prevalence of chronic diseases. WILMINGTON, DE, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report, titled, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on July 30, 2025 - 13:10 GMT

Medical Coding Market Growth Fueled by Healthcare Digitization | DataM Intelligence

Medical coding market will grow rapidly on rising healthcare data volumes, automation, and investments in AI-powered coding platforms. TEXAS, TX, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Medical coding is the process of translating …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:09 GMT

Hemodialysis and Peritoneal Dialysis Market | Facts That Everyone Must Know

The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. WILMINGTON, DE, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Allied Market Research published a report …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:00 GMT

Interventional Radiology Market to Grow at 5% CAGR Through 2031, Driven by AI & Minimally Invasive Care

DataM Intelligence highlights a tech-driven surge in image-guided procedures across oncology, cardiology, and neuro care reshaping modern diagnostics. LOS ANGELES, CA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The Interventional …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:00 GMT

The Carousel Center Renews Certified Autism Center™ Status, Expands Commitment to Sensory-Friendly, Inclusive Support

The Carousel Center has been a Certified Autism Center™ since 2023. AUSTINTOWN, OH, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The International Board of Credentialing and Continuing Education Standards (IBCCES) proudly renews the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:00 GMT

Contraline Exercises License Option for NES/T, the First Male Contraceptive to Reach Late-Stage Development

CHARLOTTESVILLE, VA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Contraline, Inc., a clinical-stage biotechnology company developing novel male contraceptives, today announced that it has exercised its option to exclusively license the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:00 GMT

Diamond Therapeutics initiates dosing in first-ever Phase 2a clinical trial evaluating low-dose psilocybin for anxiety

Double-blind, placebo-controlled study explores daily non-psychedelic doses of psilocybin for individuals with Generalized Anxiety Disorder TORONTO, ONTARIO, CANADA, July 30, 2025 /⁨EINPresswire.com⁩/ -- Diamond Therapeutics Inc. ("Diamond…

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 13:00 GMT

Faex Health Begins Research Toward AI-Powered Colorectal Cancer Detection Through Stool Imaging

Faex Health, a digital health company, announced development of early research focused on detecting preliminary patterns associated with colorectal cancer. BOULDER, CO, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Faex Health, a digital …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:59 GMT

Blujin, Corp. to Debut Resume Explorer at HR Tech 2025

For the First-Time Anywhere, Blujin Will Be Showcasing the Next Generation in Resume Matching and Ranking for Recruiting and Talent Acquisition NEW YORK, NY, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Blujin, Corp. to Debut Resume …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on July 30, 2025 - 12:53 GMT

Stress Management Market Driven by Mental Health Awareness & Digital Solutions | DataM Intelligence

Rising workplace stress and digital wellness tools fuel the stress management market toward robust growth over the next decade. TEXAS, TX, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The stress management market encompasses digital …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:41 GMT

Givzey | Version2.ai’s Patent Pending Virtual Engagement Officer (VEO) Surpasses $2M Raised From Donors In 10 Months

Autonomous Fundraising Further Cemented in Fundraising’s Future, Scratching the Surface of What’s Possible, Crossing $2 Million Threshold BOSTON, MA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Version2.ai, Givzey’s AI research and …

Distribution channels: Business & Economy, Companies ...
Published on July 30, 2025 - 12:31 GMT

MOPE Clinic Highlights Clomiphene/Enclomiphene as Innovative Alternatives to Testosterone Replacement Therapy for Men

The Pros and Cons of Boosting Natural Testosterone Production with Selective Estrogen Receptor Modulators (SERMs) METAIRIE, LA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- Metairie, LA– As the conversation around men’s hormonal health continues …

Distribution channels: Business & Economy, Consumer Goods ...
Published on July 30, 2025 - 12:30 GMT

Thrombectomy Devices Market to Reach $2.31B by 2031, Fueled by Stroke Burden and Tech Innovation

DataM Intelligence projects 5.8% CAGR as demand grows for minimally invasive clot removal amid rising stroke incidence and aging population. LOS ANGELES, CA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The Thrombectomy Devices market size …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:30 GMT

Optical Coherence Tomography Market to Hit $2.8B by 2031, Fueled by Eye Care and Cardiology Demand

DataM Intelligence projects 8.7% CAGR as OCT expands beyond ophthalmology into cardiovascular, dermatology, and oncology diagnostics. LOS ANGELES, CA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The Optical Coherence Tomography (OCT) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:30 GMT

Sleep Apnea Devices Market to Reach $14B by 2031, Driven by Home-Based Care and Smart Diagnostics

DataM Intelligence forecasts 7.9% CAGR as wearable tech, AI-powered therapies, and growing diagnosis rates reshape the sleep apnea care landscape. LOS ANGELES, CA, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- The Sleep Apnea Devices market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on July 30, 2025 - 12:29 GMT

Robotimize Wins 'Tech for Good' Award at SG60 for Advancing Global Rehabilitation Through Inclusive Innovation

Celebrating Singapore’s 60th anniversary, Robotimize is recognised for revolutionising rehabilitation with AI-driven, inclusive healthcare solutions. SINGAPORE, July 30, 2025 /⁨EINPresswire.com⁩/ -- Robotimize Group, a global leader in intelligent …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on July 30, 2025 - 12:18 GMT

Wet Glue Labels Market Aims to Expand at Double-Digit Growth Rate by 2031

The global wet glue labels market is projected to reach $16.1 billion by 2031, growing at a CAGR of 6.8% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, July 30, 2025 /⁨EINPresswire.com⁩/ -- According to the report published by Allied Market Research, …

Distribution channels: Food & Beverage Industry, Healthcare & Pharmaceuticals Industry ...